Clinical trial NCT01721655 - References

Bronchopulmonary Dysplasia — Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease

Citation(s)

•   Albersheim SG, Solimano AJ, Sharma AK, Smyth JA, Rotschild A, Wood BJ, Sheps SB
  Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. J Pediatr. 1989 Oct;115(4):615-20.
•   Biniwale MA, Ehrenkranz RA
  The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol. 2006 Aug;30(4):200-8. Review.
•   Brion LP, Primhak RA, Ambrosio-Perez I
  Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2002;(1):CD001817. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD001817.
•   Engelhardt B, Blalock WA, DonLevy S, Rush M, Hazinski TA
  Effect of spironolactone-hydrochlorothiazide on lung function in infants with chronic bronchopulmonary dysplasia. J Pediatr. 1989 Apr;114(4 Pt 1):619-24.
•   Gien J, Kinsella JP
  Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr. 2011 Jun;23(3):305-13. doi: 10.1097/MOP.0b013e328346577f. Review.
•   Hoffman DJ, Gerdes JS, Abbasi S
  Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial. J Perinatol. 2000 Jan-Feb;20(1):41-5.
•   Jeng SF, Hsu CH, Tsao PN, Chou HC, Lee WT, Kao HA, Hung HY, Chang JH, Chiu NC, Hsieh WS
  Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birthweight infants. Dev Med Child Neurol. 2008 Jan;50(1):51-7. doi: 10.1111/j.1469-8749.2007.02011.x.
•   Jobe AH, Bancalari E
  Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9.
•   Jobe AH, Ikegami M
  Mechanisms initiating lung injury in the preterm. Early Hum Dev. 1998 Nov;53(1):81-94. Review.
•   Jobe AJ
  The new BPD: an arrest of lung development. Pediatr Res. 1999 Dec;46(6):641-3. Review.
•   Kao LC, Durand DJ, McCrea RC, Birch M, Powers RJ, Nickerson BG
  Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994 May;124(5 Pt 1):772-81.
•   Kao LC, Warburton D, Cheng MH, Cedeño C, Platzker AC, Keens TG
  Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics. 1984 Jul;74(1):37-44.
•   Northway WH Jr, Rosan RC, Porter DY
  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357-68.
•   Segar JL
  Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol. 2012 Mar;39(1):209-20. doi: 10.1016/j.clp.2011.12.007. Review.
•   Shah PS
  Current perspectives on the prevention and management of chronic lung disease in preterm infants. Paediatr Drugs. 2003;5(7):463-80. Review.
•   Smith VC, Zupancic JA, McCormick MC, Croen LA, Greene J, Escobar GJ, Richardson DK
  Trends in severe bronchopulmonary dysplasia rates between 1994 and 2002. J Pediatr. 2005 Apr;146(4):469-73.
•   Spitzer A
  The role of the kidney in sodium homeostasis during maturation. Kidney Int. 1982 Apr;21(4):539-45. Review.
•   Sulyok E, Varga F, Györy E, Jobst K, Csaba IF
  Postnatal development of renal sodium handling in premature infants. J Pediatr. 1979 Nov;95(5 Pt 1):787-92.
•   Tropea K, Christou H
  Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia. Int J Pediatr. 2012;2012:598606. doi: 10.1155/2012/598606.

Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease

Details for clinical trial NCT01721655